Jul. 27, 2022

MK-0159

oral CD38 inhibitor in vivo efficacy in a murine model of cardiac I/R from the previously disclosed inhibitor CD38i J. Med. Chem. Mitobridge (an Astellas Company), Cambridge, MA

drughunter.com
Drug Hunter Team
Loading...

twitterlinkedinemail

Other molecules you may be interested in